 | • レポートコード：MRC2107A024 • 出版社/出版日：Transparency Market Research / 2021年6月30日 • レポート形態：英文、PDF、232ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Site Licence | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Enterprise Licence | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートでは、呼吸器インターベンションの世界市場を広く調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品タイプ別（気管支鏡、電磁ナビゲーション気管支鏡検査システム、胸膜鏡、呼吸器内視鏡装置、気道ステント）分析、疾患別分析、エンドユーザー別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの項目を掲載しています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・呼吸器インターベンションの世界市場規模：製品タイプ別（気管支鏡、電磁ナビゲーション気管支鏡検査システム、胸膜鏡、呼吸器内視鏡装置、気道ステント） ・呼吸器インターベンションの世界市場規模：疾患別 ・呼吸器インターベンションの世界市場規模：エンドユーザー別 ・呼吸器インターベンションの世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Interventional Pulmonology Market – Scope of Report
TMR’s report on the global interventional pulmonology market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the revenue of the global interventional pulmonology market for the period of 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global interventional pulmonology market for the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global interventional pulmonology market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of top-down and bottom-up approaches to study various phenomena in the global interventional pulmonology market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global interventional pulmonology market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global interventional pulmonology market. The next section of the global interventional pulmonology market report highlights the USPs such as interventional pulmonology market regulatory scenario (by region), key industry events, disease prevalence & incidence rate globally, COVID-19 pandemic impact on industry (value chain and short-/ mid-/ long-term impact), volume (no. of procedures), and key success factors of top players operating in the global interventional pulmonology market.
The report also delves into the competitive landscape of the global interventional pulmonology market. Key players operating in the global interventional pulmonology market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, strategic overview, and SWOT are some of the attributes of players in the global interventional pulmonology market profiled in this report.
Key Questions Answered in Interventional Pulmonology Market Report
What are the major drivers, restraints, opportunities in the market?
What are the revenue share projections of key segments of the global interventional pulmonology market during the forecast period?
Which segment is likely to lead the global interventional pulmonology market in terms of revenue by 2031?
How technological developments by the players are widening the scope for the global interventional pulmonology market?
What is the market position of different companies operating in the global interventional pulmonology market?
Interventional Pulmonology Market – Research Objectives and Research Approach
The comprehensive report on the global interventional pulmonology market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind the study and healthcare compliances laid down by accredited agencies in the purview of research in the global interventional pulmonology market. It is followed by market introduction, market dynamics, and an overview of the global interventional pulmonology market, which includes TMR analysis of market drivers, restraints, and opportunities affecting the growth of the global interventional pulmonology market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the global interventional pulmonology market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global interventional pulmonology market in terms of product type, indication, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the interventional pulmonology market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Interventional Pulmonology Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Interventional Pulmonology Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
5. Key Insights
5.1. Regulatory Scenario by Region/globally
5.2. Key Industry Events
5.3. Disease Prevalence & Incidence Rate globally with key countries
5.4. COVID-19 Impact Analysis
5.5. Volume (No. of Procedures)
6. Global Interventional Pulmonology Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Product Type, 2017–2031
6.3.1. Bronchoscopes
6.3.1.1. Flexible Bronchoscopes
6.3.1.2. Endobronchial Ultrasound Bronchoscopes (EBUS)
6.3.2. Electromagnetic Navigation Bronchoscopy Systems
6.3.3. Pleuroscopes
6.3.4. Respiratory Endotherapy Devices
6.3.4.1. Aspiration Needles
6.3.4.2. Biopsy Forceps
6.3.4.3. Biopsy Brush
6.3.4.4. Biopsy Needles
6.3.4.5. Drainage Catheter
6.3.4.6. Pulmonary Catheter
6.3.4.7. Balloon Dilatation Catheter
6.3.4.8. Others (airway retrieval basket, airway suction catheter)
6.3.5. Airway Stents
6.3.6. Pleural Catheters
6.3.7. Endobronchial Valves
6.3.8. Bronchial Thermoplasty Systems
6.4. Market Attractiveness Analysis, by Product Type
7. Global Interventional Pulmonology Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Indication, 2017–2031
7.3.1. Asthma
7.3.2. COPD
7.3.3. Lung Cancer
7.3.4. Tracheal & Bronchial Stenosis
7.3.5. Others
7.4. Market Attractiveness Analysis, by Indication
8. Global Interventional Pulmonology Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Diagnostic Centers
8.3.4. Specialty Clinics
8.3.5. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Interventional Pulmonology Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value & Volume Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Interventional Pulmonology Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Product Type, 2017–2031
10.2.1. Bronchoscopes
10.2.1.1. Flexible Bronchoscopes
10.2.1.2. Endobronchial Ultrasound Bronchoscopes (EBUS)
10.2.2. Electromagnetic Navigation Bronchoscopy Systems
10.2.3. Pleuroscopes
10.2.4. Respiratory Endotherapy Devices
10.2.4.1. Aspiration Needles
10.2.4.2. Biopsy Forceps
10.2.4.3. Biopsy Brush
10.2.4.4. Biopsy Needles
10.2.4.5. Drainage Catheter
10.2.4.6. Pulmonary Catheter
10.2.4.7. Balloon Dilatation Catheter
10.2.4.8. Others (airway retrieval basket, airway suction catheter)
10.2.5. Airway Stents
10.2.6. Pleural Catheters
10.2.7. Endobronchial Valves
10.2.8. Bronchial Thermoplasty Systems
10.3. Market Value Forecast, by Indication, 2017–2031
10.3.1. Asthma
10.3.2. COPD
10.3.3. Lung Cancer
10.3.4. Tracheal & Bronchial Stenosis
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Diagnostic Centers
10.4.4. Specialty Clinics
10.4.5. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Indication
10.6.3. By End-user
10.6.4. By Country
11. Europe Interventional Pulmonology Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Product Type, 2017–2031
11.2.1. Bronchoscopes
11.2.1.1. Flexible Bronchoscopes
11.2.1.2. Endobronchial Ultrasound Bronchoscopes (EBUS)
11.2.2. Electromagnetic Navigation Bronchoscopy Systems
11.2.3. Pleuroscopes
11.2.4. Respiratory Endotherapy Devices
11.2.4.1. Aspiration Needles
11.2.4.2. Biopsy Forceps
11.2.4.3. Biopsy Brush
11.2.4.4. Biopsy Needles
11.2.4.5. Drainage Catheter
11.2.4.6. Pulmonary Catheter
11.2.4.7. Balloon Dilatation Catheter
11.2.4.8. Others (airway retrieval basket, airway suction catheter)
11.2.5. Airway Stents
11.2.6. Pleural Catheters
11.2.7. Endobronchial Valves
11.2.8. Bronchial Thermoplasty Systems
11.3. Market Value Forecast, by Indication, 2017–2031
11.3.1. Asthma
11.3.2. COPD
11.3.3. Lung Cancer
11.3.4. Tracheal & Bronchial Stenosis
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Diagnostic Centers
11.4.4. Specialty Clinics
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Indication
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Interventional Pulmonology Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Product Type, 2017–2031
12.2.1. Bronchoscopes
12.2.1.1. Flexible Bronchoscopes
12.2.1.2. Endobronchial Ultrasound Bronchoscopes (EBUS)
12.2.2. Electromagnetic Navigation Bronchoscopy Systems
12.2.3. Pleuroscopes
12.2.4. Respiratory Endotherapy Devices
12.2.4.1. Aspiration Needles
12.2.4.2. Biopsy Forceps
12.2.4.3. Biopsy Brush
12.2.4.4. Biopsy Needles
12.2.4.5. Drainage Catheter
12.2.4.6. Pulmonary Catheter
12.2.4.7. Balloon Dilatation Catheter
12.2.4.8. Others (airway retrieval basket, airway suction catheter)
12.2.5. Airway Stents
12.2.6. Pleural Catheters
12.2.7. Endobronchial Valves
12.2.8. Bronchial Thermoplasty Systems
12.3. Market Value Forecast, by Indication, 2017–2031
12.3.1. Asthma
12.3.2. COPD
12.3.3. Lung Cancer
12.3.4. Tracheal & Bronchial Stenosis
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Diagnostic Centers
12.4.4. Specialty Clinics
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Indication
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Interventional Pulmonology Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Product Type, 2017–2031
13.2.1. Bronchoscopes
13.2.1.1. Flexible Bronchoscopes
13.2.1.2. Endobronchial Ultrasound Bronchoscopes (EBUS)
13.2.2. Electromagnetic Navigation Bronchoscopy Systems
13.2.3. Pleuroscopes
13.2.4. Respiratory Endotherapy Devices
13.2.4.1. Aspiration Needles
13.2.4.2. Biopsy Forceps
13.2.4.3. Biopsy Brush
13.2.4.4. Biopsy Needles
13.2.4.5. Drainage Catheter
13.2.4.6. Pulmonary Catheter
13.2.4.7. Balloon Dilatation Catheter
13.2.4.8. Others (airway retrieval basket, airway suction catheter)
13.2.5. Airway Stents
13.2.6. Pleural Catheters
13.2.7. Endobronchial Valves
13.2.8. Bronchial Thermoplasty Systems
13.3. Market Value Forecast, by Indication, 2017–2031
13.3.1. Asthma
13.3.2. COPD
13.3.3. Lung Cancer
13.3.4. Tracheal & Bronchial Stenosis
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Diagnostic Centers
13.4.4. Specialty Clinics
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Indication
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Interventional Pulmonology Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value & Volume Forecast, by Product Type, 2017–2031
14.2.1. Bronchoscopes
14.2.1.1. Flexible Bronchoscopes
14.2.1.2. Endobronchial Ultrasound Bronchoscopes (EBUS)
14.2.2. Electromagnetic Navigation Bronchoscopy Systems
14.2.3. Pleuroscopes
14.2.4. Respiratory Endotherapy Devices
14.2.4.1. Aspiration Needles
14.2.4.2. Biopsy Forceps
14.2.4.3. Biopsy Brush
14.2.4.4. Biopsy Needles
14.2.4.5. Drainage Catheter
14.2.4.6. Pulmonary Catheter
14.2.4.7. Balloon Dilatation Catheter
14.2.4.8. Others (airway retrieval basket, airway suction catheter)
14.2.5. Airway Stents
14.2.6. Pleural Catheters
14.2.7. Endobronchial Valves
14.2.8. Bronchial Thermoplasty Systems
14.3. Market Value Forecast, by Indication, 2017–2031
14.3.1. Asthma
14.3.2. COPD
14.3.3. Lung Cancer
14.3.4. Tracheal & Bronchial Stenosis
14.3.5. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Diagnostic Centers
14.4.4. Specialty Clinics
14.4.5. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Indication
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. Argon Medical
15.2.1.1. Company Description
15.2.1.2. Business Overview
15.2.1.3. Strategic Overview
15.2.1.4. SWOT Analysis
15.2.2. Body Vision Medical Ltd.
15.2.2.1. Company Description
15.2.2.2. Business Overview
15.2.2.3. Strategic Overview
15.2.2.4. SWOT Analysis
15.2.3. Boston Scientific Corporation
15.2.3.1. Company Description
15.2.3.2. Business Overview
15.2.3.3. Financial Overview
15.2.3.4. Strategic Overview
15.2.3.5. SWOT Analysis
15.2.4. C. R. Bard, Inc. (Becton, Dickinson and Company)
15.2.4.1. Company Description
15.2.4.2. Business Overview
15.2.4.3. Financial Overview
15.2.4.4. Strategic Overview
15.2.4.5. SWOT Analysis
15.2.5. CONMED Corporation
15.2.5.1. Company Description
15.2.5.2. Business Overview
15.2.5.3. Financial Overview
15.2.5.4. Strategic Overview
15.2.5.5. SWOT Analysis
15.2.6. Cook Medical
15.2.6.1. Company Description
15.2.6.2. Business Overview
15.2.6.3. Strategic Overview
15.2.6.4. SWOT Analysis
15.2.7. ENDO-FLEX GmbH
15.2.7.1. Company Description
15.2.7.2. Business Overview
15.2.7.3. SWOT Analysis
15.2.8. Fujifilm Holding Corporation
15.2.8.1. Company Description
15.2.8.2. Business Overview
15.2.8.3. Financial Overview
15.2.8.4. Strategic Overview
15.2.8.5. SWOT Analysis
15.2.9. KARL STORZ
15.2.9.1. Company Description
15.2.9.2. Business Overview
15.2.9.3. Strategic Overview
15.2.9.4. SWOT Analysis
15.2.10. Medtronic plc
15.2.10.1. Company Description
15.2.10.2. Business Overview
15.2.10.3. Financial Overview
15.2.10.4. Strategic Overview
15.2.10.5. SWOT Analysis
15.2.11. Olympus Corporation
15.2.11.1. Company Description
15.2.11.2. Business Overview
15.2.11.3. Financial Overview
15.2.11.4. Strategic Overview
15.2.11.5. SWOT Analysis
15.2.12. Pennine Healthcare
15.2.12.1. Company Description
15.2.12.2. Business Overview
15.2.12.3. SWOT Analysis
15.2.13. PENTAX Medical (HOYA)
15.2.13.1. Company Description
15.2.13.2. Business Overview
15.2.13.3. Financial Overview
15.2.13.4. Strategic Overview
15.2.13.5. SWOT Analysis
15.2.14. Pulmonx Corporation
15.2.14.1. Company Description
15.2.14.2. Business Overview
15.2.14.3. Financial Overview
15.2.14.4. Strategic Overview
15.2.14.5. SWOT Analysis
15.2.15. Richard Wolf GmbH
15.2.15.1. Company Description
15.2.15.2. Business Overview
15.2.15.3. Strategic Overview
15.2.15.4. SWOT Analysis
15.2.16. Rocket Medical plc
15.2.16.1. Company Description
15.2.16.2. Business Overview
15.2.16.3. Strategic Overview
15.2.16.4. SWOT Analysis
15.2.17. TAEWOONG
15.2.17.1. Company Description
15.2.17.2. Business Overview
15.2.17.3. SWOT Analysis
15.2.18. Vygon S.A.
15.2.18.1. Company Description
15.2.18.2. Business Overview
15.2.18.3. Strategic Overview
15.2.18.4. SWOT Analysis
Table 01: Global Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Product Type, 2017–2031
Table 03: Global Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 04: Global Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 05: Global Interventional Pulmonology Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 06: Global Interventional Pulmonology Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 07: Global Interventional Pulmonology Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 08: Global Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Region, 2017–2031
Table 09: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 10: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 11: North America Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Product Type, 2017–2031
Table 12: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 13: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 14: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 15: North America Interventional Pulmonology Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 18: Europe Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Product Type, 2017–2031
Table 19: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 20: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 21: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 22: Europe Interventional Pulmonology Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 23: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 24: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 25: Asia Pacific Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Product Type, 2017–2031
Table 26: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 27: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 28: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 29: Asia Pacific Interventional Pulmonology Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 30: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 31: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 32: Latin America Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Product Type, 2017–2031
Table 33: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 34: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 35: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 36: Latin America Interventional Pulmonology Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 37: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 38: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 39: Middle East & Africa Interventional Pulmonology Market Volume (Thousand Units) Forecast, by Product Type, 2017–2031
Table 40: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 41: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 42: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 43: Middle East & Africa Interventional Pulmonology Market Value (US$ Mn) Forecast, by End-user, 2017–2031